Sleep Aids: Technologies and Global Markets

Published - Jun 2014| Analyst - Natana Raj| Code - HLC081B
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

The global market for sleep aids totaled $54.9 billion in 2013. This market is estimated to grow at a compound annual growth rate (CAGR) of 5.6% to reach $58.5 billion in 2014 and $76.7 billion by 2019.

Report Includes

  • An overview of the global market for sleep aids and related technologies.
  • Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Identification of the different disorders that manifest with sleep disorder symptoms.
  • Information on different methods used to enhance sleep including medications, devices, and laboratories.
  • Details on emerging technologies and developing trends.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

Insomnia, sleep apnea, restless leg syndrome (RLS), bruxism, narcolepsy and sleepwalking are all serious sleep disorders that bring about negative health consequences. Often undiagnosed and thus not treated, sleep disorders can not only take a toll on personal health but can also adverse effects on personal relationships and reduce worker productivity. In examining the steep increase in a variety of sleep disorders, this report will analyze the causes and available treatments for sleep disorder sufferers. This report describes in detail the overall market for sleep aids and then gives an account of the segment revenues.

REASONS FOR STUDY

This BCC Research study provides the latest highlights in the exciting area of sleep disorders. Research on the working of the human brain in relation to sleep is a fairly new area, with many new and novel theories. The discovery of new mechanisms and chemicals in the brain has provided expanding avenues for research and development (R&D) of products that are likely to alter the course of sleep disorders or modify the outcome. This study analyzes the current therapies for sleep disorders and new therapies that are in the pipeline. The report provides the latest information on leading products and R&D initiatives in the area of sleep disorders. Moreover, the report gives an extensive review of the market leading firms in this sector.

SCOPE OF STUDY

This analysis primarily focuses on the following sleep disorders:

  • Insomnia.
  • Sleep apnea.
  • RLS.
  • Bruxism.
  • Narcolepsy.
  • Sleepwalking.

The report discusses products, trends, new developments and compensation issues that are currently affecting or are likely to affect the market soon. Analyses are provided for each of the key companies in the major and minor market segments. The sleep aids and diagnostic centers discussed in this report include:

  • Medications.
    • Prescriptions.
    • Over-the-counter (OTC).
    • Herbal remedies.
  • Sleep laboratories.
  • Sleep apnea devices.
  • Mattresses and pillows.

All markets are further broken down into specific types of products that are discussed in detail, measuring current and potential market size, identifying current and potential market drivers, detailing from 2013, 2014 and 2019, and assessing the competitors in the market and their shares in respective markets.

METHODOLOGY AND INFORMATION SOURCES

Both primary and secondary research methodologies were used in preparing this research report. The information and analysis presented are based on extensive first-hand interviews with primary executives, product managers, clinical specialists and doctors involved in the sleep disorders arena. Background information was obtained from various government, business, medical journal and trade magazines sources. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as to formulate market projections.

ANALYST’S CREDENTIALS

P. Natana Raj is a medical analyst and has edited 24 market research reports in the past eight years, covering pharmaceuticals, medical devices, stem cells and beverages. He is a retired college professor with 32 years of experience in teaching biochemistry, biotechnology, biochemical pharmacology, molecular biology and genetics. Besides an M.Sc degree, he also holds diplomas in biochemistry, biochemical pharmacology, biotechnology and environmental biology.

BCC RESEARCH WEBSITE

The BCC Research website, located at www.bccresearch.com, enables visitors to:

  • Conduct keyword searches.
  • Examine the complete BCC Research catalog of market research reports and place direct orders.
  • Read announcements of recently published reports.
  • View titles of near-term upcoming reports.
  • Sign up to receive E-mail notifications when reports are published in selected categories.
  • Contact BCC Research for additional information.

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and is of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. BCC Research and the author assume no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Apr-2010| Analyst - Mary Anne Crandall| Code - HLC081A

Report Highlights

  • The worldwide sleep aids markets reached revenues of $25 billion in 2009. Revenues are anticipated to reach $33.2 billion in 2014, growing at a compound annual growth rate (CAGR) of 5.8% over the forecast period of 2009 to 2014.
  • The largest market in terms of annual revenues is the mattresses and pillows segment, but it is currently the slowest growing of all the markets. This segment was worth $10.6 billion in 2009 and is expected to reach $12.5 billion by 2015, a compound annual growth rate (CAGR) of 3.3%.
  • The second-largest market is sleep laboratories, with revenues of $6.7 billion in 2009. This segment is expected to grow at a compound annual growth rate (CAGR) of 6.5% to reach $9.2 billion in 2014.
Want to Customize this Report?

Contact us for a confidential discussion.

781-205-2433

Custom Report
RELATED REPORTS
Share This Report